Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/27247

Type
Article
Copyright
Restricted access
Embargo date
2030-01-01
Sustainable Development Goals
03 Saúde e Bem-Estar
Collections
Share

Statistics
Metadata
Show full item record

EFFECTIVINESS OF NEURAMINIDASE INHIBITORS IN REDUCING MORTALITY IN HOSPITALIZED INFLUENZA A (H1N1)PDM09 PATIENTS: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSYS
Siqueira, Marilda Agudo Mendonça Teixeira de et al. | Date Issued: 2014
Author
Siqueira, Marilda Agudo Mendonça Teixeira de
Múltipla autoria - ver em Notas
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratório.e Sarampo. Rio de Janeiro, RJ. Brasil.
Múltipla autoria - ver em Notas
Abstract
Neuraminidase inhibitors were widely used during the 2009–10 influenza A H1N1 pandemic, but evidence for their effectiveness in reducing mortality is uncertain. We did a meta-analysis of individual participant data to investigate the association between use of neuraminidase inhibitors and mortality in patients admitted to hospital with pandemic influenza A H1N1pdm09 virus infection.
Keywords in Portuguese
Efetividade
inibidores da neuraminidase
Redução de mortalidade
Pacientes hospitalizados
gripe A H1N1
infecção viral
 
Keywords
Effectiveness
neuraminidase inhibitors
reducing mortality
hospital
influenza A H1N1
virus infectio
 
Publisher
Elsevier
Citation
MUTHURI, Stella G. et al. Effectiviness of Neuraminidase inhibitors in reducing mortality in hospitalised Influenza A (H1N1)pdm09 patientss: an individual participant data meta-analysis. The Lancet Respiratory Medicine, v.2, n.5, p.395-404, May 2014.
DOI
10.1016/S2213-2600(14)70041-4
ISSN
2213-2600
Notes
Front author affiliations can be found on pp 25-29 †List of PRIDE Consortium Investigators’ can be found on pages 20, and affiliations listed in appendix pp 1-6